Michael V. Ortiz, MD
Pediatric Hematologist-Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Rare Pediatric Tumors
- Kidney Cancers, Liver Cancers, Sarcomas
- Relapsed and Refractory Solid Tumors in Children and Young Adults
Request an Appointment
About Me
- Associate Attending Pediatrician
I am a pediatric oncologist on the MSK Kids team who cares for children and young adults with solid tumors. I have particular expertise in treating pediatric kidney cancers such as Wilms’ tumor and rhabdoid tumor, pediatric liver cancers such as hepatoblastoma and fibrolamellar carcinoma, and pediatric sarcomas. Through a combination of quality care, education, and research, I strive to improve the outcomes and experiences of children with cancer.
Read more
In addition to caring for patients, I conduct research focused on translating basic scientific discoveries from the laboratory into safer and more effective treatments for children and young adults with challenging solid tumors. I investigate how these cancers become resistant to standard treatments, screen new drugs in laboratory models of childhood cancers, and identify markers to predict which patients would benefit from these additional therapies. Ultimately through my research, I hope to move the most promising treatments from the lab and into the clinic to help patients with cancers that have become resistant to standard therapies.
At MSK Kids, I am honored to work with a dedicated team of healthcare professionals. Our doctors, nurse practitioners, nurses, pharmacists, social workers, and others are committed to providing the best possible care for every child and family.
- Clinical Expertise: Rare Pediatric Tumors; Kidney Cancers, Liver Cancers, Sarcomas; Relapsed and Refractory Solid Tumors in Children and Young Adults; Developmental Therapeutics
- Languages Spoken: English
- Education: MD, University of Florida
- Residencies: Pediatrics - Children’s National Medical Center
- Fellowships: Pediatric Hematology/Oncology – Memorial Sloan Kettering Cancer Center
A pediatric hematologist-oncologist is a doctor who treats cancers and blood diseases in children, adolescents and young adults.
My Specialties
- Rare Pediatric Tumors
- Kidney Cancers, Liver Cancers, Sarcomas
- Relapsed and Refractory Solid Tumors in Children and Young Adults
- Developmental Therapeutics
Education
- MD, University of Florida
Residencies
- Pediatrics - Children’s National Medical Center
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
Fellowships
- Pediatric Hematology/Oncology – Memorial Sloan Kettering Cancer Center
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Ortiz sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Ortiz
- A Phase 2 Study of Selinexor in People with Wilms' Tumors and Other Solid Tumors
- A Phase I Study of Codrituzumab in Children and Young Adults with Recurrent or Persistent Solid Tumors
- A Phase II Study of Combination Chemotherapy, Surgery, and Radiation Therapy for Patients with High-Risk Wilms' Tumors
- Renal Tumor Classification, Biology, and Banking Study
Read more
- Clinical Trials Co-Investigated by Dr. Ortiz
- A Phase I/II Study of Alectinib in Children and Adolescents with Solid Tumors or Central Nervous System Tumors Containing a Change in the ALK Gene
- A Phase I/II Study of Tiragolumab and Atezolizumab for Children and Adults with Recurrent or Persistent SMARCB1- or SMARCA4-Deficient Tumors
- A Phase III Study Evaluating Less Intensive Ways to Treat Germ Cell Tumors
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Ortiz’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michael V. Ortiz discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.